寿仙谷：以标准话语权 叩开中医药国际化之门

Core Viewpoint - The establishment of a standard system is crucial for the internationalization of traditional Chinese medicine (TCM), providing a pathway for core products to enter overseas markets and allowing Shouxiangu (寿仙谷) to find a differentiated breakthrough in this process [1] Group 1: International Standardization Efforts - Shouxiangu has led and participated in the formulation of over 100 TCM-related standards, including 8 international standards, with 5 already published, using standardization as a tool to promote TCM's internationalization [1][2] - The company shifted its focus to international standardization after facing challenges with registering TCM as pharmaceuticals abroad, such as long approval cycles and high clinical costs [2] - The ISO international standards for Lingzhi and Dendrobium, initiated in 2011, were officially published between 2018 and 2019 and are now applied in 31 countries and regions, including the US, Canada, Australia, and Germany [2] Group 2: Key Developments in Standardization - The ISO international standard for broken-wall Lingzhi spore powder, set to be implemented by July 2025, fills a gap in global quality specifications for this product, establishing key parameters and safety limits [3] - The inclusion of Ganoderic acid A as a core quality evaluation index in the standards reflects the differentiation of raw materials and the transformation of quality characteristics into internationally recognized technical language [3] Group 3: Technological Foundation and R&D - Shouxiangu positions itself as a technology-driven enterprise, investing in all aspects of the industry chain, including breeding, cultivation, processing, and product development, to ensure product safety and effectiveness [4] - The company has developed a standardized system for the entire TCM industry chain, successfully breeding 12 new varieties of medicinal materials and obtaining multiple patents for its purification technology [4] - R&D expenses reached 9.79% of revenue in the first three quarters of 2025, an increase of 3.15 percentage points year-on-year, with the number of R&D personnel growing to 179, accounting for 16.1% of the total workforce [4] Group 4: Business Performance and Market Strategy - In the third quarter of 2025, Shouxiangu achieved revenue of 130 million yuan, a year-on-year increase of 8.51%, with online channel revenue growing by 11.80% and its share of total revenue rising from 18.97% to 23.92% [6] - The company is expanding its product line and targeting younger consumers, launching new products like Dendrobium pomelo juice and various snacks, with a focus on affordability and appealing packaging [6] - Shouxiangu is also prioritizing the cultivation of saffron, having successfully bred two new varieties with high active ingredient content, and is advancing related evidence-based medical research [6]